Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. (2017)

First Author: Loughran SJ
Attributed to:  Establishment of the Cambridge Single Cell Analysis Clinical Core Facility [SCACCF] funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20161827

PubMed Identifier: 28899870

Publication URI: http://europepmc.org/abstract/MED/28899870

Type: Journal Article/Review

Volume: 214

Parent Publication: The Journal of experimental medicine

Issue: 10

ISSN: 0022-1007